MedPath

NATIONAL INSTITUTE ON DRUG ABUSE AND ADDICTION

πŸ‡΅πŸ‡°Pakistan
Ownership
-
Employees
-
Market Cap
-
Website

Behavioral Smoking Cessation Treatment - 1

Not Applicable
Completed
Conditions
Tobacco Use Disorder
First Posted Date
2005-05-16
Last Posted Date
2017-01-12
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
304
Registration Number
NCT00110825
Locations
πŸ‡ΊπŸ‡Έ

Stanford Stop Smoking Program, San Jose, California, United States

Smoking Treatment of Prisoners

Phase 3
Completed
Conditions
Tobacco Use Cessation
Tobacco Use Disorder
First Posted Date
2005-05-11
Last Posted Date
2017-01-12
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
250
Registration Number
NCT00110630
Locations
πŸ‡ΊπŸ‡Έ

Virginia Commonwealth University, Richmond, Virginia, United States

Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1

Phase 1
Conditions
Cocaine-Related Disorders
First Posted Date
2004-12-23
Last Posted Date
2017-01-11
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
24
Registration Number
NCT00100113
Locations
πŸ‡ΊπŸ‡Έ

U of Texas Medical Branch Galveston, Galveston, Texas, United States

Modafinil for the Treatment of Cocaine Dependence - 1

Phase 2
Completed
Conditions
Cocaine-Related Disorders
First Posted Date
2004-12-23
Last Posted Date
2017-01-12
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
210
Registration Number
NCT00100100
Locations
πŸ‡ΊπŸ‡Έ

Cincinnati Addiction Research Center, Cincinnati, Ohio, United States

πŸ‡ΊπŸ‡Έ

New York VA Medical Center, New York, New York, United States

πŸ‡ΊπŸ‡Έ

Boston University Medical Center, Boston, Massachusetts, United States

and more 3 locations

To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1

Phase 1
Conditions
Amphetamine-Related Disorders
First Posted Date
2004-12-23
Last Posted Date
2017-01-11
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
8
Registration Number
NCT00100074
Locations
πŸ‡ΊπŸ‡Έ

U of CA, San Francisco, San Francisco, California, United States

Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1

Phase 1
Conditions
Cocaine-Related Disorders
First Posted Date
2004-10-15
Last Posted Date
2017-01-11
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
16
Registration Number
NCT00094315
Locations
πŸ‡ΊπŸ‡Έ

University of Texas Health Science Center, San Antonio, Texas, United States

Interactions Between Cocaine and Ethanol and Disulfiram - 1

Phase 1
Conditions
Alcohol-Related Disorders
Cocaine-Related Disorders
First Posted Date
2004-10-15
Last Posted Date
2017-01-11
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
16
Registration Number
NCT00094289
Locations
πŸ‡ΊπŸ‡Έ

University of Texas Hlth Sci Ctr San Ant, San Antonio, Texas, United States

πŸ‡ΊπŸ‡Έ

UCLA Integrated Substance Abuse Program, Los Angeles, California, United States

GBR 12909 Study in Cocaine Experienced African American Volunteers - 1

Phase 1
Conditions
Cocaine-Related Disorders
First Posted Date
2004-08-11
Last Posted Date
2017-01-11
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
10
Registration Number
NCT00089687
Locations
πŸ‡ΊπŸ‡Έ

Uniformed Services University of Health Science, Bethesda, Maryland, United States

Assessment of Interactions Between Methamphetamine and Aripiprazole - 1

Phase 1
Conditions
Amphetamine-Related Disorders
First Posted Date
2004-08-06
Last Posted Date
2017-01-11
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
17
Registration Number
NCT00089440
Locations
πŸ‡ΊπŸ‡Έ

New York University, School of Medicine, New York, New York, United States

πŸ‡ΊπŸ‡Έ

UCLA Integrated Substance Abuse Program, Los Angeles, California, United States

Maintaining Abstinence in Chronic Cigarette Smokers - 1

Phase 2
Completed
Conditions
Tobacco Use Disorder
Interventions
First Posted Date
2004-07-19
Last Posted Date
2017-01-12
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
407
Registration Number
NCT00087880
Locations
πŸ‡ΊπŸ‡Έ

University California, San Francisco, San Francisco, California, United States

Β© Copyright 2025. All Rights Reserved by MedPath